Studies immune problems linked to clonal hematopoiesis and VEXAS syndrome
Observes adults with immune and inflammatory conditions, with or without clonal hematopoiesis.
Plain-language title generated from the registry record
Registry title: Clonal Hematopoiesis of Immunological Significance
Key facts
- Where
- Paris, FranceSee the site
Where in France
- AP-HP, Service de médecine interne, Hôpital Saint AntoineParis, FranceNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Assistance Publique - Hôpitaux de Paris
- Trial code
- NCT05969821
- Record updated
- 23 March 2026
- Original description
Ambispective, national, multicenter observational cohort study aimed at characterizing the satellite dysimmune manifestations of clonal hematopoiesis, including Vexas (Vacuoles, E1 enzyme, X-linked, Autoinflammatory and Somatic) syndrome.Read full original descriptionShow less
Immuno-inflammatory Manifestations With or Without Clonal Hematopoiesis: Ambispective Cohort Study
Ambispective, national, multicenter observational cohort study aimed at characterizing the satellite dysimmune manifestations of clonal hematopoiesis, including Vexas (Vacuoles, E1 enzyme, X-linked, Autoinflammatory and Somatic) syndrome.
Inclusion: Age >=18 years old; Confirmed dysimmune manifestations: clinical or biological abnormality or systemic disease; Presence or absence of myeloid or lymphoid blood disease according to World Health Organization (WHO) classification.
Exclusion: Persons benefiting from special protection: adults under guardianship and curatorship; People hospitalized without their consent and not protected by law; persons deprived of liberty; Persons not affiliated to the social security system.